tyrosyl-prolyl-leucyl-glycinamide has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kastin, AJ; Pan, W | 1 |
1 review(s) available for tyrosyl-prolyl-leucyl-glycinamide and Parkinson Disease
| Article | Year |
|---|---|
From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
Topics: Analgesics; Animals; Binding Sites; Blood-Brain Barrier; Depression; Dyskinesia, Drug-Induced; Humans; MSH Release-Inhibiting Hormone; Oligopeptides; Parkinson Disease; Rats; Receptors, Opioid | 2007 |